新辅助化疗在局部晚期食管癌中的应用进展(3)
參考文献：
[1]Chen MF，Yang YH，Lai CH，et al.Outcome of patients with esophageal cancer：a nationwide analysis[J].Ann Surg Oncol，2013，20(9)：3023-3030.
[2]杨冉，韩金利，张卫民，等.新辅助化疗在进展期食管癌中的疗效分析[J].中国肿瘤临床，2014，41(2)：119-122.
[3]Atsumi K，Shioyama Y，Arimura H，et al.Esophageal stenosis associated with tumor regression in radiotherapy for esophageal cancer：frequency and prediction[J].Int J Radiat Oncol Biol Phys，2012，82(5)：1973-1980.
, http://www.100md.com
[4]Amdal CD，Jacobsen AB，Guren MG，et al.Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer：a systematic review[J].Acta Oncol，2013，52(4)：679-690.
[5]Ku GY，Ilson DH.Chemotherapeutic options for gastroesophageal junction tumors[J].Semin Radiat Oncol，2013，23(1)：24-30.
[6]Medical Research Council Oesophageal Cancer Working Group.Surgical resection with or without preoperative chemotherapy in oesophageal cancer：a randomised controlled trial[J].Lancet，2002(359)：1727-1733.
, 百拇医药
[7]Allum WH，Stenning SP，Bancewicz J，et al.Long-term results of a randomised trial of surgery with or without preoperative chemotherapy in oesophageal cancer[J].J Clin Oncol，2009(27)：5062-5067.
[8]Ychou M，Boige V，Pignon JP，et al.Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma：an FNCLCC and FFCD multicenter phase Ⅲ trial[J].J Clin Oncol，2011，29(13)：1715-1721.
[9]Boonstra JJ，Kok TC，Wijnhoven BP，et al.Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma：long-term results of a randomised controlled trial[J].BMC Cancer 2011(11)：181.
, 百拇医药
[10]Sjoquist KM，Burmeister BH，Smithers BM，et al.Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma：an updated meta-analysis[J].Lancet Oncol，2011(12)：681-692.
[11]Almhanna K，Strosberg JR.Multimodality approach for locally advanced esophageal cancer[J].World J Gastroenterol，2012，18(40)：5679-5687.
[12]Thallinger CM，Kiesewetter B，Raderer M，et al.Pre-and postoperative treatment modalities for esophageal squamous cell carcinoma[J].Anticancer Res，2012，32(11)：4609-4627.
, 百拇医药
[13]Kranzfelder M，Schuster T，Geinitz H，et al.Meta-analysis of neoadjuvant treatment modalities and definitive nonsurgical therapy for oesophageal squamous cell cancer[J].Br J Surg，2011，98(6)：768-783.
[14]Tercioti Junior V，Lopes LR，Coelho Neto Jde S，et al.Local effectiveness and complications of neoadjuvant therapy in esophageal squamous cell carcinoma：radiotherapy versus chemoradiotherapy[J].Rev Col Bras Cir，2011，38(4)：227-234., 百拇医药(胡国梁 杜铭)
[1]Chen MF，Yang YH，Lai CH，et al.Outcome of patients with esophageal cancer：a nationwide analysis[J].Ann Surg Oncol，2013，20(9)：3023-3030.
[2]杨冉，韩金利，张卫民，等.新辅助化疗在进展期食管癌中的疗效分析[J].中国肿瘤临床，2014，41(2)：119-122.
[3]Atsumi K，Shioyama Y，Arimura H，et al.Esophageal stenosis associated with tumor regression in radiotherapy for esophageal cancer：frequency and prediction[J].Int J Radiat Oncol Biol Phys，2012，82(5)：1973-1980.
, http://www.100md.com
[4]Amdal CD，Jacobsen AB，Guren MG，et al.Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer：a systematic review[J].Acta Oncol，2013，52(4)：679-690.
[5]Ku GY，Ilson DH.Chemotherapeutic options for gastroesophageal junction tumors[J].Semin Radiat Oncol，2013，23(1)：24-30.
[6]Medical Research Council Oesophageal Cancer Working Group.Surgical resection with or without preoperative chemotherapy in oesophageal cancer：a randomised controlled trial[J].Lancet，2002(359)：1727-1733.
, 百拇医药
[7]Allum WH，Stenning SP，Bancewicz J，et al.Long-term results of a randomised trial of surgery with or without preoperative chemotherapy in oesophageal cancer[J].J Clin Oncol，2009(27)：5062-5067.
[8]Ychou M，Boige V，Pignon JP，et al.Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma：an FNCLCC and FFCD multicenter phase Ⅲ trial[J].J Clin Oncol，2011，29(13)：1715-1721.
[9]Boonstra JJ，Kok TC，Wijnhoven BP，et al.Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma：long-term results of a randomised controlled trial[J].BMC Cancer 2011(11)：181.
, 百拇医药
[10]Sjoquist KM，Burmeister BH，Smithers BM，et al.Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma：an updated meta-analysis[J].Lancet Oncol，2011(12)：681-692.
[11]Almhanna K，Strosberg JR.Multimodality approach for locally advanced esophageal cancer[J].World J Gastroenterol，2012，18(40)：5679-5687.
[12]Thallinger CM，Kiesewetter B，Raderer M，et al.Pre-and postoperative treatment modalities for esophageal squamous cell carcinoma[J].Anticancer Res，2012，32(11)：4609-4627.
, 百拇医药
[13]Kranzfelder M，Schuster T，Geinitz H，et al.Meta-analysis of neoadjuvant treatment modalities and definitive nonsurgical therapy for oesophageal squamous cell cancer[J].Br J Surg，2011，98(6)：768-783.
[14]Tercioti Junior V，Lopes LR，Coelho Neto Jde S，et al.Local effectiveness and complications of neoadjuvant therapy in esophageal squamous cell carcinoma：radiotherapy versus chemoradiotherapy[J].Rev Col Bras Cir，2011，38(4)：227-234., 百拇医药(胡国梁 杜铭)
参见：首页 > 医疗版 > 疾病专题 > 消化内科 > 食管疾病 > 食管癌